PATENT CLAIM ANALYSIS

Application Number: 15914800
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "006000"]

Abstract:
The invention is a novel MECP2E1 splice variant and its corresponding polypeptide. The invention also includes methods of using these nucleic acid sequences and proteins in medical diagnosis and treatment of neuropsychiatric disorders or development disorders.

Claim (Index 20):
The nucleic acid probe of  claim 15 , wherein the probe is 15-25 nucleotides long.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.22581
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12313251', '15914770', '11352153', '14100889', '12657559']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7347574214589331
- 35 USC 102 Novelty (BERT): 0.6041416057321869
- Combined Prediction Score: 0.7216958398862585
- Mean Citation Score: 543.3589479999998
- Max Citation Score: 560.99493
- Similarity Product: 489.1904762874644

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test